Related Experiment Video
Updated: Jul 4, 2026

Using the Race Model Inequality to Quantify Behavioral Multisensory Integration Effects
Published on: May 10, 2019
Reevaluating the Use of Race/Ethnicity in the MESA Risk Score
Quinn White1, Spencer Hansen1, Brittany Saldivar Murphy2
1University of Washington Seattle WA USA.
Insights
A new race-free MESA risk score estimates coronary heart disease risk comparably to the original. This cardiovascular disease tool performs similarly in calibration and discrimination, offering a more inclusive approach.
Area of Science:
- Cardiovascular disease research
- Biostatistics
- Public health
Background:
- Cardiovascular disease risk scores are widely used in clinical practice and research.
- The Multi-Ethnic Study of Atherosclerosis (MESA) risk score estimates 10-year coronary heart disease risk.
- The original MESA score incorporated race/ethnicity, necessitating careful consideration of its inclusion.
Purpose of the Study:
- To develop and evaluate a race-free version of the MESA risk score.
- To compare the performance of the race-free MESA score against the original score.
- To assess the impact of removing race/ethnicity on cardiovascular risk prediction.
Main Methods:
- Utilized data from the MESA cohort (individuals aged 45-84, free of prevalent cardiovascular disease).
- Employed a 2-step regularization procedure: LASSO for variable selection and ridge regression for preventing overfitting.
- Excluded race/ethnicity and interaction terms with race/ethnicity as candidate predictors.
Main Results:
- The race-free MESA risk score achieved an area under the ROC curve of 0.820 (95% CI, 0.801-0.840).
- No significant difference was observed in the area under the ROC curve compared to the original score (estimate, 0.0032).
- The discrimination slope for the race-free model (0.101) was comparable to the original MESA risk score (0.0937).
Conclusions:
- A race-free MESA risk score was successfully developed.
- The race-free score demonstrates comparable calibration and discrimination to the original MESA risk score.
- This study provides a validated, race-independent tool for cardiovascular disease risk assessment.
Background:
Cardiovascular disease risk scores are widespread in research and clinical settings. The MESA (Multi-Ethnic Study of Atherosclerosis) risk score estimates the 10-year risk of coronary heart disease and was novel in its use of coronary artery calcium alongside traditional risk factors, including race/ethnicity. However, including race/ethnicity in a risk score model requires careful consideration. We developed a race-free MESA risk score and compared it with the original.
Methods:
We used data from the MESA cohort, a community-based cohort of individuals aged 45 to 84 years who identified as White, Hispanic/Latino, Black, or Chinese and were free of prevalent cardiovascular disease upon study entry, to develop a race-free risk score estimating 10-year coronary heart disease risk. We used the same 2-step regularization procedure as that for the original MESA risk score: (1) least absolute shrinkage and selection operator for variable selection, and (2) ridge regression to prevent overfitting. Neither race/ethnicity nor any interaction term with race/ethnicity was included as a candidate predictor.
Results:
When excluding race/ethnicity, several interaction terms were retained that were not retained in the original MESA risk score. The area under the receiver operating characteristic curve for the race-free risk score was 0.820 (95% CI, 0.801-0.840), and the difference in area under the receiver operating characteristic curve was not significant (estimate, 0.0032 [95% CI, -0.0008 to 0.0073]). The discrimination slope in the race-free model was 0.101, while that of the original MESA risk score was 0.0937.
Conclusions:
We developed a race-free MESA risk score that performs comparably to the MESA risk score in both calibration and discrimination.
Related Concept Videos
Stereotypes, Prejudice, and Discrimination
Bias in Epidemiological Studies
Ethnic Identity within a Larger Culture
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Regression Toward the Mean
Sources of Self-Esteem III: Social Comparison
